Evidence map›Paper›PMID 35862857›Full record

ArticleACS chemical biology2022

Simple, Rapid Chemical Labeling and Screening of Antibodies with Luminescent Peptides.

Virginia A Kincaid, Hui Wang, Casey A Sondgeroth, Emily A Torio, Valerie T Ressler, Connor Fitzgerald, Mary P Hall, Robin Hurst, Monika G Wood, Julia K Gilden and 7 more

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. CRISPR RiPCA for Investigating eIF4E-mACS chemical biology · 2025
    Article
  4. Article
  5. Article
  6. Split-Protein Therapeutic Platforms: Identifying Binder Pairs.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Virginia A KincaidPromega Corporation, Madison, Wisconsin 53711, United States.ORCID 0000-0002-0053-4577
Hui WangPromega Biosciences LLC, San Luis Obispo, California 93401, United States.
Casey A SondgerothPromega Corporation, Madison, Wisconsin 53711, United States.
Emily A TorioPromega Corporation, Madison, Wisconsin 53711, United States.
Valerie T ResslerPromega Corporation, Madison, Wisconsin 53711, United States.
Connor FitzgeraldPromega Biosciences LLC, San Luis Obispo, California 93401, United States.
Mary P HallPromega Corporation, Madison, Wisconsin 53711, United States.
Robin HurstPromega Corporation, Madison, Wisconsin 53711, United States.
Monika G WoodPromega Corporation, Madison, Wisconsin 53711, United States.
Julia K GildenPromega Corporation, Madison, Wisconsin 53711, United States.
Thomas A KirklandPromega Biosciences LLC, San Luis Obispo, California 93401, United States.ORCID 0000-0003-0859-5785
Dan LazarPromega Corporation, Madison, Wisconsin 53711, United States.
Hsu Chia-ChangPromega Corporation, Madison, Wisconsin 53711, United States.
Lance P EncellPromega Corporation, Madison, Wisconsin 53711, United States.
Thomas MachleidtPromega Corporation, Madison, Wisconsin 53711, United States.
Wenhui ZhouPromega Biosciences LLC, San Luis Obispo, California 93401, United States.
Melanie L DartPromega Corporation, Madison, Wisconsin 53711, United States.ORCID 0000-0001-5429-3695
Promega (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sensitive and selective detection assays are essential for the accurate measurement of analytes in both clinical and research laboratories. Immunoassays that rely on nonoverlapping antibodies directed against the same target analyte (e.g., sandwich enzyme-linked immunosorbent assays (ELISAs)) are commonly used molecular detection technologies. Use of split enzyme reporters has simplified the workflow for these traditionally complex assays. However, identifying functional antibody pairs for a given target analyte can be cumbersome, as it generally involves generating and screening panels of antibodies conjugated to reporters. Accordingly, we sought a faster and easier reporter conjugation strategy to streamline antibody screening. We describe here the development of such a method that is based on an optimized ternary NanoLuc luciferase. This bioluminescence complementation system is comprised of a reagent-based thermally stable polypeptide (LgTrip) and two small peptide tags (β9 and β10) with lysine-reactive handles for direct conjugation onto antibodies. These reagents enable fast, single-step, wash-free antibody labeling and sensitive functional screening. Simplicity, speed, and utility of the one-pot labeling technology are demonstrated in screening antibody pairs for the analyte interleukin-4. The screen resulted in the rapid development of a sensitive homogeneous immunoassay for this clinically relevant cytokine.

Indexed as

AntibodiesPeptidesEnzyme-Linked Immunosorbent AssayImmunoassayIndicators and ReagentsLuciferasesAntibodiesIndicators and ReagentsLuciferasesnanolucPeptides

Identifiers

PMID35862857
PMCPMC9396617
OpenAlexW4286497137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.